MRI helps choose which pancreatic cancer patients can have surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The tumor is thought to be locally resectable or borderline resectable by your care team
- CT scan shows no liver metastases (no cancer spread to the liver)
- You’re at least 18 years old and can give informed consent
- Your expected diagnosis is pancreatic ductal adenocarcinoma based on CT scan
- You must be able to have an MRI (for example, not have certain kidney problems, severe claustrophobia, or a pacemaker)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
This study uses MRI scans to screen for pancreas cancer in people at high risk due to family history or certain gene mutations. It aims to see if MRI can help find cancer early.
This study tests if a special MRI scan (MRE) can better diagnose pancreatic masses. It may help doctors find and treat pancreatic cancer more accurately.
This study tests a new, harmless “disposable” setup for MRI scans to measure how pancreatic cancer treatments affect the body. It may help doctors get more accurate MRI measurements, so treatment response can be assessed better.
This trial tests a higher dose of radiation guided by MRI for people with pancreatic cancer that cannot be removed by surgery or is borderline removable. It aims to improve treatment effectiveness after initial chemotherapy.
This study tests a highly focused radiation plan that uses MRI scans to adjust treatment during therapy. It’s for people with locally advanced pancreatic cancer who have already completed a set course of chemotherapy and whose cancer hasn’t grown.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.